Pete Nash is currently the Senior Director of Patient Safety at Gilead Sciences, where they lead the Aggregate Reports and Analytics team and oversee various pharmacovigilance processes. Previously, they worked at GSK from 1997 to 2008 as a manager in global clinical safety and pharmacovigilance. Pete holds a BSc in Applied Biology from Nottingham Trent University and a PhD in Antibody Structure from the University of Birmingham.
This person is not in any teams
This person is not in any offices